Analytical Validation of a Candidate Biomarker for Neurological or Neuromuscular Disorders(U01 Clinical Trial Optional)
HHS-NIH11
POSTED: 10/02/2024
UPDATED: 01/10/2025
DUE: 06/22/2026
The purpose of this notice of funding opportunity (NOFO) is to support rigorous analytical validation of method(s) used for measuring biomarkers for neurological and neuromuscular disorders for use in...
Clinical Validation of a Candidate Biomarker for Neurological or Neuromuscular Disorders (U01 Clinical Trial Optional)
HHS-NIH11
POSTED: 10/02/2024
UPDATED: 10/02/2024
DUE: 06/22/2026
The purpose of this Program Announcement (PAR) is to enable clinical validation of strong candidate biomarkers for neurological diseases and conditions. Specifically, the goal of this PAR is to enable...
Blueprint Neurotherapeutics Network (BPN): Biologic-based Drug Discovery and Development for Disorders of the Nervous System (U44 Clinical Trial Optional)
HHS-NIH11
POSTED: 10/01/2024
UPDATED: 10/01/2024
DUE: 08/18/2027
Reissue PAR-21-233 - The Blueprint Neurotherapeutics Network for Biologics (BPN-Biologics) provides support for biologic-based therapeutic discovery and development, from lead optimization through pha...
Blueprint Neurotherapeutics Network (BPN): Biologic-based Drug Discovery and Development for Disorders of the Nervous System (UG3/UH3 Clinical Trial Optional)
HHS-NIH11
POSTED: 10/01/2024
UPDATED: 10/01/2024
DUE: 08/18/2027
The Blueprint Neurotherapeutics Network for Biologics (BPN-Biologics) provides support for biologic-based therapeutic discovery and development, from lead optimization through phase I clinical testing...
Alcohol Research-Related Resource Award (R24 Clinical Trial Not Allowed)
HHS-NIH11
POSTED: 11/30/2023
UPDATED: 11/30/2023
DUE: 09/25/2026
The purpose of the Resource-Related Research Projects (R24) grant is to support investigator-initiated resources designed to provide materials and services to support and advance biomedical research o...
Alcohol Health Services Research (R34 Clinical Trial Optional)
HHS-NIH11
POSTED: 11/27/2024
UPDATED: 11/27/2024
DUE: 09/07/2026
The National Institute on Alcohol Abuse and Alcoholism solicits applications for an R34 Clinical Trial Optional mechanism focusing on alcohol health services. This NOFO will broadly focus on closing t...
Effectiveness Trials to Test Mental Health System Interventions (R61/R33 Clinical Trial Required)
HHS-NIH11
POSTED: 11/26/2024
UPDATED: 11/27/2024
DUE: 10/15/2027
This R61/R33 concept complements NIMHs suite of clinical trial NOFOs by supporting feasibility and infrastructure development (R61) followed by well-powered clinical trials (R33) to test the effective...
Early Stage Testing of Pharmacologic or Neuromodulatory Device-based Interventions for the Treatment of Mental Disorders (R61/R33 Clinical Trial Required)
HHS-NIH11
POSTED: 11/26/2024
UPDATED: 11/27/2024
DUE: 10/15/2027
NIMH requires an experimental therapeutics approach for the development and testing of therapeutic interventions, in which studies both evaluate the clinical effect of an intervention and generate inf...
Early Stage Testing of Pharmacologic or Neuromodulatory Device-based Interventions for the Treatment of Mental Disorders (R33- Clinical Trial Required)
HHS-NIH11
POSTED: 11/26/2024
UPDATED: 11/27/2024
DUE: 10/15/2027
NIMH requires an experimental therapeutics approach for the development and testing of therapeutic interventions, in which studies both evaluate the clinical effect of an intervention and generate inf...
Development of Psychosocial Therapeutic and Preventive Interventions for Mental Disorders (R61/R33 Clinical Trial Required)
HHS-NIH11
POSTED: 11/26/2024
UPDATED: 11/27/2024
DUE: 10/15/2027
Development of Psychosocial Therapeutic and Preventive Interventions for Mental Disorders (R61/R33 Clinical Trial Required). As part of NIMH's clinical trials pipeline, this NOFO encourages pilot rese...